Uterine Artery Embolization

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Obstetrics & Gynecology".

Deadline for manuscript submissions: closed (30 December 2021) | Viewed by 2396

Special Issue Editors


E-Mail Website
Guest Editor

E-Mail
Guest Editor
University Hospital of Alexandroupolis, Alexandroupoli, Greece
Interests: obstetrics and gynecology

Special Issue Information

Dear Colleagues,

Uterine fibroids are high prevalent  benign tumors of women of reproductive age, causing very often symptoms (heavy menstrual bleeding, abdominal pain, anemia, pressure symptoms) that affect negatively their quality of life Uterine Artery Embolization (UAE), first described by Ravina et al in 1995, is gaining acceptance as a minimal invasive treatment alternative to surgery and her safety and efficacy mainly comparing with surgery was confirmed in several randomized controlled trials Embolization is currently the most used  non-surgical invasive technique. The majority of women report satisfactory post-treatment results like shorter hospitalization period and recovery time in comparison to hysterectomy and improvement or complete remission of clinical symptoms The treatment of fibroids should be individualized based on their size, location, growth rate, the symptoms that they cause, the desire to have children and the age of the woman.. According to results from our Department were founded no negative impact of UAE on ovarian reserve of normal menstruating premenopausal women and no important changes inflammatory parameters after the procedure. This procedure is also of great importance in the reproductive period because a discussion about the effect of fibroids on reproductive outcome is still open . In the future embolization could be generally recommended as treatment option for women who desire future fertility/pregnancy.

Prof. Panagiotis Tsikouras
Prof. Dr. Georgios Galazios
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • nonsurgical uterine fibroids treatment
  • uterine artery embolization

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

12 pages, 246 KiB  
Article
The Efficacy of Transarterial Embolization for Postpartum Hemorrhage Complicated with Disseminated Intravascular Coagulation: A Single-Center Experience
by Daigo Ochiai, Seishi Nakatsuka, Yushi Abe, Satoru Ikenoue, Yoshifumi Kasuga, Masanori Inoue, Masahiro Jinzaki and Mamoru Tanaka
J. Clin. Med. 2021, 10(18), 4082; https://doi.org/10.3390/jcm10184082 - 09 Sep 2021
Cited by 1 | Viewed by 1875
Abstract
Indications for the use of transarterial embolization (TAE) for postpartum hemorrhage (PPH) have been established. However, the efficacy of TAE for PPH complicated by disseminated intravascular coagulation (DIC) remains controversial. In this study, we investigated the efficacy of TAE for PPH complicated by [...] Read more.
Indications for the use of transarterial embolization (TAE) for postpartum hemorrhage (PPH) have been established. However, the efficacy of TAE for PPH complicated by disseminated intravascular coagulation (DIC) remains controversial. In this study, we investigated the efficacy of TAE for PPH complicated by DIC. A database review was conducted to identify patients who were treated with TAE for PPH at our hospital. TAE was performed in 41 patients during the study period. Effective hemostasis was achieved in all cases, but additional procedures, such as re-embolization or hysterectomy, were required in five patients (12.2%). The typical causes of PPH included uterine atony (18 cases), placenta previa (15 cases), amniotic fluid embolism (DIC-type) (11 cases), and placenta accreta spectrum (10 cases). The mean blood loss was 3836 mL. The mean obstetrical DIC and the International Society on Thrombosis and Hemostasis DIC scores were 7.9 and 2.6, respectively. The efficacy of hemostasis was comparable between patients with and without DIC. However, the complete success rate of TAE was lower in patients with DIC as the condition worsened than that in non-DIC patients. Overall, TAE is effective as a minimally invasive treatment for PPH complicated by DIC. Full article
(This article belongs to the Special Issue Uterine Artery Embolization)
Back to TopTop